Natus Medical Incorporated provided earnings guidance for the fourth quarter and year ending December 31, 2020. For the fourth quarter 2020, the Company's revenue guidance is expected to be between $104.0 million and $114.0 million. GAAP EPS Guidance to be $0.07 - $0.19. For the full year 2020, the Company's revenue guidance is expected to be between $401.0 million and $411.0 million. GAAP LPS Guidance to be $0.57 - $0.46.